<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmccellbiol&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Cell Biology - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmccellbiol/</link>
        <description>The latest research articles published by BMC Cell Biology</description>
        <dc:date>2009-11-30T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/84" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/83" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/82" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/81" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/80" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/79" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/78" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/77" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/76" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2121/10/75" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/84">
        <title>Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src</title>
        <description>Background:
Epidermal growth factor receptor (EGFR) controls a wide range of cellular processes, and altered EGFR signaling contributes to human cancer.  EGFR kinase domain mutants found in non-small cell lung cancer (NSCLC) are constitutively active, a trait critical for cell transformation through activation of downstream pathways.  Endocytic trafficking of EGFR is a major regulatory mechanism as ligand-induced lysosomal degradation results in termination of signaling.  While numerous studies have examined mutant EGFR signaling, the endocytic traffic of mutant EGFR within the NSCLC milieu remains less clear.
Results:
This study shows that mutant EGFRs in NSCLC cell lines are constitutively endocytosed as shown by their colocalization with the early/recycling endosomal marker transferrin and the late endosomal/lysosomal marker LAMP1.  Notably, mutant EGFRs, but not the wild-type EGFR, show a perinuclear accumulation and colocalization with recycling endosomal markers such as Rab11 and EHD1 upon treatment of cells with endocytic recycling inhibitor monensin, suggesting that mutant EGFRs preferentially traffic through the endocytic recycling compartments.  Importantly, monensin treatment enhanced the mutant EGFR association and colocalization with Src, indicating that aberrant transit through the endocytic recycling compartment promotes mutant EGFR-Src association.
Conclusions:
The findings presented in this study show that mutant EGFRs undergo aberrant traffic into the endocytic recycling compartment which allows mutant EGFRs to engage in a preferential interaction with Src, a critical partner for EGFR-mediated oncogenesis.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/84</link>
                <dc:creator>Byung Min Chung</dc:creator>
                <dc:creator>Srikumar Raja</dc:creator>
                <dc:creator>Robert Clubb</dc:creator>
                <dc:creator>Chun Tu</dc:creator>
                <dc:creator>Manju George</dc:creator>
                <dc:creator>Vimla Band</dc:creator>
                <dc:creator>Hamid Band</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:84</dc:source>
        <dc:date>2009-11-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-84</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>84</prism:startingPage>
        <prism:publicationDate>2009-11-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/83">
        <title>Novel interactions of CLN5 support molecular networking between Neuronal Ceroid Lipofuscinosis proteins</title>
        <description>Background:
Neuronal ceroid lipofuscinoses (NCLs) comprise at least eight genetically characterized neurodegenerative disorders of childhood. Despite of genetic heterogeneity, the high similarity of clinical symptoms and pathology of different NCL disorders suggest cooperation between different NCL proteins and common mechanisms of pathogenesis. Here, we have studied molecular interactions between NCL proteins, concentrating specifically on the interactions of CLN5, the protein underlying the Finnish variant late infantile form of NCL (vLINCLFin).
Results:
We found that CLN5 interacts with several other NCL proteins namely, CLN1/PPT1, CLN2/TPP1, CLN3, CLN6 and CLN8. Furthermore, analysis of the intracellular targeting of CLN5 together with the interacting NCL proteins revealed that over-expression of PPT1 can facilitate the lysosomal transport of mutated CLN5FinMajor, normally residing in the ER and in the Golgi complex. The significance of the novel interaction between CLN5 and PPT1 was further supported by the finding that CLN5 was also able to bind the F1-ATPase, earlier shown to interact with PPT1.
Conclusions:
We have described novel interactions between CLN5 and several NCL proteins, suggesting a modifying role for these proteins in the pathogenesis of individual NCL disorders. Among these novel interactions, binding of CLN5 to CLN1/PPT1 is suggested to be the most significant one, since over-expression of PPT1 was shown to influence on the intracellular trafficking of mutated CLN5, and they were shown to share a binding partner outside the NCL protein spectrum.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/83</link>
                <dc:creator>Annina Lyly</dc:creator>
                <dc:creator>Carina von Schantz</dc:creator>
                <dc:creator>Claudia Heine</dc:creator>
                <dc:creator>Mia-Lisa Schmiedt</dc:creator>
                <dc:creator>Tessa Sipila</dc:creator>
                <dc:creator>Anu Jalanko</dc:creator>
                <dc:creator>Aija Kyttala</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:83</dc:source>
        <dc:date>2009-11-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-83</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>83</prism:startingPage>
        <prism:publicationDate>2009-11-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/82">
        <title>Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies</title>
        <description>Background:
Active pre-mRNA splicing occurs co-transcriptionally, and takes place throughout the nucleoplasm of eukaryotic cells. Splicing decisions are controlled by networks of nuclear RNA-binding proteins and their target sequences, sometimes in response to signalling pathways. Sam68 (Src-associated in mitosis 68 kDa) is the prototypic member of the STAR (Signal Transduction and Activation of RNA) family of RNA-binding proteins, which regulate splicing in response to signalling cascades. Nuclear Sam68 protein is concentrated within subnuclear organelles called SLM/Sam68 Nuclear Bodies (SNBs), which also contain some other splicing regulators, signalling components and nucleic acids.
Results:
We used proteomics to search for the major interacting protein partners of nuclear Sam68. In addition to Sam68 itself and known Sam68-associated proteins (heterogeneous nuclear ribonucleoproteins hnRNP A1, A2/B1 and G), we identified hnRNP L as a novel Sam68-interacting protein partner. hnRNP L protein was predominantly present within small nuclear protein complexes approximating to the expected size of monomers and dimers, and was quantitatively associated with nucleic acids. hnRNP L spatially co-localised with Sam68 as a novel component of SNBs and was also observed within the general nucleoplasm. Localisation within SNBs was highly specific to hnRNP L and was not shared by the closely-related hnRNP LL protein, nor any of the other Sam68-interacting proteins we identified by proteomics. The interaction between Sam68 and hnRNP L proteins was observed in a cell line which exhibits low frequency of SNBs suggesting that this association also takes place outside SNBs. Although ectopic expression of hnRNP L and Sam68 proteins independently affected splicing of CD44 variable exon v5 and TJP1 exon 20 minigenes, these proteins did not, however, co-operate with each other in splicing regulation of these target exons.
Conclusion:
Here we identify hnRNP L as a novel SNB component. We show that, compared with other identified Sam68-associated hnRNP proteins and hnRNP LL, this co-localisation within SNBs is specific to hnRNP L. Our data suggest that the novel Sam68-hnRNP L protein interaction may have a distinct role within SNBs.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/82</link>
                <dc:creator>Prabhakar Rajan</dc:creator>
                <dc:creator>Caroline Dalgliesh</dc:creator>
                <dc:creator>Cyril Bourgeois</dc:creator>
                <dc:creator>Monika Heiner</dc:creator>
                <dc:creator>Kaveh Emami</dc:creator>
                <dc:creator>Emma Clark</dc:creator>
                <dc:creator>Albrecht Bindereif</dc:creator>
                <dc:creator>James Stevenin</dc:creator>
                <dc:creator>Craig Robson</dc:creator>
                <dc:creator>Hing Leung</dc:creator>
                <dc:creator>David Elliott</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:82</dc:source>
        <dc:date>2009-11-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-82</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>82</prism:startingPage>
        <prism:publicationDate>2009-11-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/81">
        <title>The proline-rich domain of tau plays a role in interactions with actin</title>
        <description>Background:
The microtubule-associated protein tau is able to interact with actin and serves as a cross-linker between the microtubule and actin networks. The microtubule-binding domain of tau is known to be involved in its interaction with actin. Here, we address the question of whether the other domains of tau also interact with actin.
Results:
Several tau truncation and deletion mutants were constructed, namely N-terminal region (tauN), proline-rich domain (tauPRD), microtubule binding domain (tauMTBD) and C-terminal region (tauC) truncation mutants, and microtubule binding domain (tau&#916;MTBD) and proline-rich domain/microtubule binding domain (tau&#916;PRD&amp;MTBD) deletion mutants. The proline-rich domain truncation mutant (tauPRD) and the microtubule binding domain deletion mutant (tau&#916;MTBD) promoted the formation of actin filaments. However, actin assembly was not observed in the presence of the N-terminal and C-terminal truncation mutants. These results indicate that the proline-rich domain is involved in the association of tau with G-actin. Furthermore, results from co-sedimentation, solid phase assays and electron microscopy showed that the proline-rich domain is also capable of binding to F-actin and inducing F-actin bundles. Using solid phase assays to analyze apparent dissociation constants for the binding of tau and its mutants to F-actin resulted in a sequence of affinity for F-actin: tau &gt;&gt; microtubule binding domain &gt; proline-rich domain. Moreover, we observed that the proline-rich domain was able to associate with and bundle F-actin at physiological ionic strength.
Conclusion:
The proline-rich domain is a functional structure playing a role in the association of tau with actin. This suggests that the proline-rich domain and the microtubule-binding domain of tau are both involved in binding to and bundling F-actin.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/81</link>
                <dc:creator>Hai Jin He</dc:creator>
                <dc:creator>Xing Sheng Wang</dc:creator>
                <dc:creator>Rong Pan</dc:creator>
                <dc:creator>Dong Liang Wang</dc:creator>
                <dc:creator>Ming Nan Liu</dc:creator>
                <dc:creator>Rong Qiao He</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:81</dc:source>
        <dc:date>2009-11-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-81</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>81</prism:startingPage>
        <prism:publicationDate>2009-11-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/80">
        <title>Cbl-Associated Protein is tyrosine phosphorylated by c-Abl and c-Src kinases</title>
        <description>Background:
The c-Cbl-associated protein (CAP), also known as ponsin, localizes to focal adhesions and stress fibers and is involved in signaling events. Phosphorylation has been described for the other two members of the sorbin homology family, vinexin and ArgBP2, but no data exist about the putative phosphorylation of CAP. According to previous findings, CAP binds to tyrosine kinase c-Abl. However, it is not known if CAP is a substrate of c-Abl or other tyrosine kinases or if phosphorylation regulates its localization.
Results:
We here show that CAP is Tyr phosphorylated by and interacts with both c-Abl and c-Src. One major phosphorylation site, Tyr360, and two minor contributors Tyr326 and Tyr632 were identified as Abl phosphorylation sites, whereas Src preferentially phosphorylates Tyr326 and Tyr360. Phosphorylation of CAP was not necessary for its localization to focal adhesions and stress fibers, but Tyr326Phe substitution alters the function of CAP during cell spreading.
Conclusion:
This is the first demonstration of phosphorylation of CAP by any kinase. Our findings suggest that coordinated action of Src and Abl might regulate the function of CAP and reveal a functional role especially for the Src-mediated Tyr phosphorylation of CAP in cell spreading.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/80</link>
                <dc:creator>Inga Fernow</dc:creator>
                <dc:creator>Ana Tomasovic</dc:creator>
                <dc:creator>Ann Siehoff-Icking</dc:creator>
                <dc:creator>Ritva Tikkanen</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:80</dc:source>
        <dc:date>2009-11-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-80</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>80</prism:startingPage>
        <prism:publicationDate>2009-11-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/79">
        <title>RNAi mediated acute depletion of Retinoblastoma protein (pRb) promotes aneuploidy in human primary cells via micronuclei formation</title>
        <description>Background:
Changes in chromosome number or structure as well as supernumerary centrosomes and multipolar mitoses are commonly observed in human tumors. Thus, centrosome amplification and mitotic checkpoint dysfunctions are believed possible causes of chromosomal instability. The Retinoblastoma tumor suppressor (RB) participates in the regulation of synchrony between DNA synthesis and centrosome duplication and it is involved in transcription regulation of some mitotic genes. Primary human fibroblasts were transfected transiently with short interfering RNA (siRNA) specific for human pRb to investigate the effects of pRb acute loss on chromosomal stability.
Results:
Acutely pRb-depleted fibroblasts showed altered expression of genes necessary for cell cycle progression, centrosome homeostasis, kinetochore and mitotic checkpoint proteins. Despite altered expression of genes involved in the Spindle Assembly Checkpoint (SAC) the checkpoint seemed to function properly in pRb-depleted fibroblasts. In particular AURORA-A and PLK1 overexpression suggested that these two genes might have a role in the observed genomic instability. However, when they were post-transcriptionally silenced in pRb-depleted fibroblasts we did not observe reduction in the number of aneuploid cells. This finding suggests that overexpression of these two genes did not contribute to genomic instability triggered by RB acute loss although it affected cell proliferation. Acutely pRb-depleted human fibroblasts showed the presence of micronuclei containing whole chromosomes besides the presence of supernumerary centrosomes and aneuploidy.
Conclusion:
Here we show for the first time that RB acute loss triggers centrosome amplification and aneuploidy in human primary fibroblasts. Altogether, our results suggest that pRb-depleted primary human fibroblasts possess an intact spindle checkpoint and that micronuclei, likely caused by mis-attached kinetochores that in turn trigger chromosome segregation errors, are responsible for aneuploidy in primary human fibroblasts where pRb is acutely depleted.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/79</link>
                <dc:creator>Angela Amato</dc:creator>
                <dc:creator>Laura Lentini</dc:creator>
                <dc:creator>Tiziana Schillaci</dc:creator>
                <dc:creator>Flora Iovino</dc:creator>
                <dc:creator>Aldo Di Leonardo</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:79</dc:source>
        <dc:date>2009-11-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-79</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>79</prism:startingPage>
        <prism:publicationDate>2009-11-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/78">
        <title>HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells</title>
        <description>Background:
Knowledge about signaling pathways is typically compiled based on data gathered using different cell lines. This approach implicitly assumes that the cell line dependence is not important. However, different cell lines do not always respond to a particular stimulus in the same way, and lack of coherent data collected from closely related cellular systems can be detrimental to the efforts to understand the regulation of biological processes. To address this issue, we created a clone library of human mammary epithelial (HME) cells that expresses different levels of HER2 and HER3 receptors in combination with endogenous EGFR/HER1. Using our clone library, we have quantified the receptor activation patterns and systematically tested the validity of the existing hypotheses about the interaction patterns between HER1-3 receptors.
Results:
Our study identified HER2 as the dominant dimerization partner for both EGFR and HER3. Contrary to earlier suggestions, we find that lateral interactions with HER2 do not lead to strong transactivation between EGFR and HER3, i.e., EGFR activation and HER3 activation are only weakly linked in HME cells. We also find that observed weak transactivation is uni-directional where stimulation of EGFR leads to HER3 activation whereas HER3 stimulation does not activate the EGFR. Repeating our experiments at lower cell confluency established that cell confluency is not a major factor in the observed interaction patterns. We have also quantified the dependence of the kinetics of Erk and Akt activation on different HER receptors. We found that HER3 signaling makes the strongest contribution to Akt activation and that, stimulation of either EGFR or HER3 leads to significant Erk activation.
Conclusion:
Our study shows that clone cell libraries can be a powerful resource in systems biology research by making it possible to differentiate between various hypotheses in a consistent cellular background. Using our constructed clone library we profiled the cell signaling patterns to establish the role of HER2 in the crosstalk between EGFR and HER3 receptors in HME cells. Our results for HME cells show that the weak linkage between EGFR and HER3 pathways can lead to distinct downstream cellular signaling patterns in response to the ligands of these two receptors.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/78</link>
                <dc:creator>Yi Zhang</dc:creator>
                <dc:creator>Lee Opresko</dc:creator>
                <dc:creator>Harish Shankaran</dc:creator>
                <dc:creator>William Chrisler</dc:creator>
                <dc:creator>H. Steven Wiley</dc:creator>
                <dc:creator>Haluk Resat</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:78</dc:source>
        <dc:date>2009-10-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-78</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>78</prism:startingPage>
        <prism:publicationDate>2009-10-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/77">
        <title>Ethanol exerts dual effects on calcium homeostasis in CCK-8-stimulated mouse pancreatic acinar cells</title>
        <description>Background:
A significant percentage of patients with pancreatitis often presents a history of excessive alcohol consumption. Nevertheless, the patho-physiological effect of ethanol on pancreatitis remains poorly understood. In the present study, we have investigated the early effects of acute ethanol exposure on CCK-8-evoked Ca2+ signals in mouse pancreatic acinar cells. Changes in [Ca2+]i and ROS production were analyzed employing fluorescence techniques after loading cells with fura-2 or CM-H2DCFDA, respectively.
Results:
Ethanol, in the concentration range from 1 to 50 mM, evoked an oscillatory pattern in [Ca2+]i. In addition, ethanol evoked reactive oxygen species generation (ROS) production. Stimulation of cells with 1 nM or 20 pM CCK-8, respectively led to a transient change and oscillations in [Ca2+]i. In the presence of ethanol a transformation of 20 pM CCK-8-evoked physiological oscillations into a single transient increase in [Ca2+]i in the majority of cells was observed. Whereas, in response to 1 nM CCK-8, the total Ca2+ mobilization was significantly increased by ethanol pre-treatment. Preincubation of cells with 1 mM 4-MP, an inhibitor of alcohol dehydrogenase, or 10 &#956;M of the antioxidant cinnamtannin B-1, reverted the effect of ethanol on total Ca2+ mobilization evoked by 1 nM CCK-8. Cinnamtannin B-1 blocked ethanol-evoked ROS production.
Conclusion:
ethanol may lead, either directly or through ROS generation, to an over stimulation of pancreatic acinar cells in response to CCK-8, resulting in a higher Ca2+ mobilization compared to normal conditions. The actions of ethanol on CCK-8-stimulation of cells create a situation potentially leading to Ca2+ overload, which is a common pathological precursor that mediates pancreatitis.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/77</link>
                <dc:creator>Marcela Fernandez-Sanchez</dc:creator>
                <dc:creator>Angel del Castillo-Vaquero</dc:creator>
                <dc:creator>Gines Salido</dc:creator>
                <dc:creator>Antonio Gonzalez</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:77</dc:source>
        <dc:date>2009-10-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-77</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>77</prism:startingPage>
        <prism:publicationDate>2009-10-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/76">
        <title>Functional characterization of the trans-membrane domain interactions of the Sec61 protein translocation complex beta-subunit</title>
        <description>Background:
In eukaryotic cells co- and post-translational protein translocation is mediated by the trimeric Sec61 complex. Currently, the role of the Sec61 complex &#946;-subunit in protein translocation is poorly understood. We have shown previously that in Saccharomyces cerevisiae the trans-membrane domain alone is sufficient for the function of the &#946;-subunit Sbh1p in co-translational protein translocation. In addition, Sbh1p co-purifies not only with the protein translocation channel subunits Sec61p and Sss1p, but also with the reticulon family protein Rtn1p.
Results:
We used random mutagenesis to generate novel Sbh1p mutants in order to functionally map the Sbh1p trans-membrane domain. These mutants were analyzed for their interactions with Sec61p and how they support co-translational protein translocation. The distribution of mutations identifies one side of the Sbh1p trans-membrane domain &#945;-helix that is involved in interactions with Sec61p and that is important for Sbh1p function in protein translocation. At the same time, these mutations do not affect Sbh1p interaction with Rtn1p. Furthermore we show that Sbh1p is found in protein complexes containing not only Rtn1p, but also the two other reticulon-like proteins Rtn2p and Yop1p.
Conclusion:
Our results identify functionally important amino acids in the Sbh1p trans-membrane domain. In addition, our results provide additional support for the involvement of Sec61&#946; in processes unlinked to protein translocation.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/76</link>
                <dc:creator>Xueqiang Zhao</dc:creator>
                <dc:creator>Jussi Jantti</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:76</dc:source>
        <dc:date>2009-10-26T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-76</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>76</prism:startingPage>
        <prism:publicationDate>2009-10-26T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2121/10/75">
        <title>Novel association of APC with intermediate filaments
identified using a new versatile APC antibody</title>
        <description>Background:
As a key player in suppression of colon tumorigenesis, Adenomatous Polyposis Coli (APC) has been widely studied to determine its cellular functions. However, inconsistencies of commercially available APC antibodies have limited the exploration of APC function. APC is implicated in spindle formation by direct interactions with tubulin and microtubule-binding protein EB1. APC also interacts with the actin cytoskeleton to regulate cell polarity. Until now, interaction of APC with the third cytoskeletal element, intermediate filaments, has remained unexamined.
Results:
We generated an APC antibody (APC-M2 pAb) raised against the 15 amino acid repeat region, and verified its reliability in applications including immunoprecipitation, immunoblotting, and immunofluorescence in cultured cells and tissue. Utilizing this APC-M2 pAb, we immunoprecipitated endogenous APC and its binding proteins from colon epithelial cells expressing wild-type APC. Using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS), we identified 42 proteins in complex with APC, including &#946;-catenin and intermediate filament (IF) proteins lamin B1 and keratin 81. Association of lamin B1 with APC in cultured cells and human colonic tissue was verified by co-immunoprecipitation and colocalization. APC also colocalized with keratins and remained associated with IF proteins throughout a sequential extraction procedure.
Conclusion:
We introduce a versatile APC antibody that is useful for cell/tissue immunostaining, immunoblotting and immunoprecipitation. We also present evidence for interactions between APC and IFs, independent of actin filaments and microtubules. Our results suggest that APC associates with all three major components of the cytoskeleton, thus expanding potential roles for APC in the regulation of cytoskeletal integrity.</description>
        <link>http://www.biomedcentral.com/1471-2121/10/75</link>
                <dc:creator>Yang Wang</dc:creator>
                <dc:creator>Yoshiaki Azuma</dc:creator>
                <dc:creator>David Friedman</dc:creator>
                <dc:creator>Robert Coffey</dc:creator>
                <dc:creator>Kristi Neufeld</dc:creator>
                <dc:source>BMC Cell Biology 2009, 10:75</dc:source>
        <dc:date>2009-10-21T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2121-10-75</dc:identifier>
        <prism:publicationName>BMC Cell Biology</prism:publicationName>
        <prism:issn>1471-2121</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>75</prism:startingPage>
        <prism:publicationDate>2009-10-21T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
